Web🎂🕯️🕯️2 years today!! What an amazing #team behind the scenes of Lys Therapeutics!! 👉🏻Fanny Potzeha, Flavie Lesept, Jean-Baptiste BERTRAND, Werner… Web15 mar. 2024 · Lys Therapeutics announces a seed round of 5.5 million euros to prepare future clinical studies for its first-in-class monoclonal antibody targeting neurovascular … Our Partners - Home - Lys Therapeutics Oral presentation – ISFP 2024. 🔬🧠 “Lys Therapeutics, first-in-class biotherapies … He holds a PhD in Neurosciences (Claude Bernard University, Lyon, France) … Lys Therapeutics announces a seed round of 5.5 million euros to prepare future … Congresses and events. Read more. September 26, 2024. …
LYS THERAPEUTICS - Lyon 7ème - l’annuaire Hoodspot
WebLys Therapeutics is a French biotech company developing innovative drugs to treat patients suffering from neurovascular or neurodegenerative disorders, including stroke and multiple sclerosis.... Web16 mar. 2024 · The Lyon-based biotech obtained funding of $600,000 (€567,025) from the American Michael J. Fox Foundation. (MJFF). These funds will be intended to finance the preclinical research of the unique drug candidate of Lys Therapeutics a monoclonal antibody first-in-class positioned on the treatment of Parkinson’s disease, glunozumab. newspaper articles on business
LYS THERAPEUTICS - Lyon 7ème - l’annuaire Hoodspot
Web22 oct. 2024 · Caen et Lyon, France, le 15 octobre 2024 – Lys Therapeutics, société de biotechnologie française développant des thérapies innovantes contre les maladies neurologiques annonce aujourd’hui avoir reçu une subvention de 600 000 euros en tant que Lauréat et Grand Prix du Concours d’innovation i-Lab pour son candidat-médicament … Web29 dec. 2024 · Press article of Lys Therapeutics in La Tribune de Lyon Congresses and events. Read more. September 28, 2024 ... Web15 oct. 2024 · Caen and Lyon, France, 15 October 2024 – Lys Therapeutics, a French biotech company developing innovative treatments for neurological pathologies, … newspaper articles on consumer rights